Latest Equities News

Sunstone Metals has reported a 33% increase in its Bramaderos gold-copper resource to 3.6 million ounces gold equivalent, alongside a maiden 1.2 million ounce resource at El Palmar. The company is gearing up for renewed drilling and advancing strategic partnerships.

Norwest Minerals has entered a three-year At-The-Market equity subscription agreement with Dolphin Corporate Investments, unlocking up to $3 million in standby capital to support its Bulgera Gold project and ongoing operations.

VRX Silica Limited has locked in six binding offtake contracts totaling nearly 1 million tonnes per annum and appointed a new CEO, marking significant progress for its Arrowsmith North silica sand project.

GoldArc Resources has consolidated 100% ownership of the Mt Stirling gold deposit and activated a $2.5 million funding facility, kickstarting a diamond drilling program to advance mining plans.

Bellevue Gold Limited reported a robust cash flow and significant debt reduction in its December 2025 quarter, ending with a strong cash position of A$165.1 million. The company made early principal repayments on its project loan facility, lowering outstanding debt to A$100 million.

Auking Mining Limited reported a cash burn in its latest quarterly report but is moving ahead with a $1.5 million capital raising to fund key exploration projects.

Finder Energy has completed its acquisition of the Petrojarl I FPSO, issuing over 37 million shares to Amplus Energy as part of the US$15 million deal. Amplus’ Managing Director joins Finder’s board, signalling deeper collaboration.

Buru Energy advances its Rafael Gas Project with strong funding interest and a $2.35 million capital raise, setting the stage for critical 2026 drilling and resource validation.

Cyprium Metals has secured $80 million in funding and advanced key infrastructure works to restart copper production at its Nifty Copper Complex, targeting first cathode output by mid-2026.

Eagle Mountain Mining has issued nearly 120 million new shares and 40 million options, raising just over $1 million, but a significant shortfall remains to be placed. The company aims to secure additional funding to advance its Arizona copper-gold projects.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.

Noble Helium has received a further unsecured loan of AUD 250,000 from its Executive Chair to support working capital, highlighting management’s confidence amid ongoing refinancing efforts.